These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22327134)

  • 1. Surgical resection as definitive treatment for refractory GVHD of the colon.
    Cornell RF; Palmer J; Komorowski R; Drobyski WR
    Bone Marrow Transplant; 2012 Oct; 47(10):1366-7. PubMed ID: 22327134
    [No Abstract]   [Full Text] [Related]  

  • 2. Colonic graft-versus-host disease.
    Ross WA; Couriel D
    Curr Opin Gastroenterol; 2005 Jan; 21(1):64-9. PubMed ID: 15687887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
    Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massive ascites of donor T-cell origin in a patient with acute GVHD after a reduced-intensity allograft for CLL.
    Ivanov V; Faucher C; Bilger K; Vey N; Sainty D; Calmels B; Chabannon C; Lafage-Pochitaloff M; Mozziconacci MJ; Mohty M; Chrestian MA; Blaise D
    Bone Marrow Transplant; 2003 Nov; 32(9):961-3. PubMed ID: 14562000
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia.
    Pavletic ZS; Arrowsmith ER; Bierman PJ; Goodman SA; Vose JM; Tarantolo SR; Stein RS; Bociek G; Greer JP; Wu CD; Kollath JP; Weisenburger DD; Kessinger A; Wolff SN; Armitage JO; Bishop MR
    Bone Marrow Transplant; 2000 Apr; 25(7):717-22. PubMed ID: 10745256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia.
    Doney KC; Chauncey T; Appelbaum FR;
    Bone Marrow Transplant; 2002 May; 29(10):817-23. PubMed ID: 12058231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hematopoietic stem cell transplantation in Chronic Lymphocytic Leukemia.
    Banerji V; Johnston JB; Seftel MD
    Transfus Apher Sci; 2007 Aug; 37(1):57-62. PubMed ID: 17919979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed graft versus leukemia effect after allogeneic peripheral stem cell transplantation in a patient with chronic lymphocytic leukemia.
    Gutiérrez A; Solano C; Prósper F; Benet I; Sarsotti E; García-Conde J
    Haematologica; 2000 Mar; 85(3):330-2. PubMed ID: 10702833
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.
    Schetelig J; Thiede C; Bornhauser M; Schwerdtfeger R; Kiehl M; Beyer J; Sayer HG; Kroger N; Hensel M; Scheffold C; Held TK; Hoffken K; Ho AD; Kienast J; Neubauer A; Zander AR; Fauser AA; Ehninger G; Siegert W;
    J Clin Oncol; 2003 Jul; 21(14):2747-53. PubMed ID: 12860954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.
    Dreger P; Brand R; Hansz J; Milligan D; Corradini P; Finke J; Deliliers GL; Martino R; Russell N; Van Biezen A; Michallet M; Niederwieser D;
    Leukemia; 2003 May; 17(5):841-8. PubMed ID: 12750695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the early regenerative therapeutic response in graft versus host disease using high definition technology with virtual i-Scan chromoendoscopy.
    Iacucci M; Daly A; Chaudhry A; Duggan P; Gui X; Love J; Ghosh S
    Endoscopy; 2013; 45 Suppl 2 UCTN():E389-90. PubMed ID: 24285063
    [No Abstract]   [Full Text] [Related]  

  • 13. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
    Ikegame K; Yoshihara S; Taniguchi Y; Kaida K; Inoue T; Okada M; Taniguchi K; Hasei H; Tamaki H; Fujioka T; Kato R; Soma T; Ogawa H
    Exp Hematol; 2011 Aug; 39(8):880-90. PubMed ID: 21689724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus.
    Schmook T; Kraft J; Benninghoff B; Nindl I; Roewert J; Ulrich C; Stockfleth E
    Bone Marrow Transplant; 2005 Jul; 36(1):87-8. PubMed ID: 15895116
    [No Abstract]   [Full Text] [Related]  

  • 15. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome.
    Skert C; Patriarca F; Sperotto A; Cerno M; Filì C; Zaja F; Stocchi R; Geromin A; Damiani D; Fanin R
    Haematologica; 2006 Feb; 91(2):258-61. PubMed ID: 16461315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
    Rondón G; Giralt S; Huh Y; Khouri I; Andersson B; Andreeff M; Champlin R
    Bone Marrow Transplant; 1996 Sep; 18(3):669-72. PubMed ID: 8879640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial.
    Ritgen M; Böttcher S; Stilgenbauer S; Bunjes D; Schubert J; Cohen S; Humpe A; Hallek M; Kneba M; Schmitz N; Döhner H; Dreger P;
    Leukemia; 2008 Jul; 22(7):1377-86. PubMed ID: 18418404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced intensity conditioning allogeneic transplant for advanced chronic lymphocytic leukemia.
    Soligo D; Motta M; Borsotti C; Ibatici A; Cortelezzi A; Lambertenghi Deliliers G
    Haematologica; 2004 Jul; 89(7):885-6. PubMed ID: 15257953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudoautologous blood stem cell transplantation for refractory chronic graft-versus-host disease.
    Pusic I; Pavletic SZ; Kessinger A; Tarantolo SR; Bishop MR
    Bone Marrow Transplant; 2002 Apr; 29(8):709-10. PubMed ID: 12180118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.